安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Homepage | SWOG
More About SWOG Cancer Research Network Clinical Trials Learn more about cancer clinical trials and how to find one Our Network Find out about our members at over 1,300 institutions worldwide SWOG Meetings Get the latest information on our biannual member meetings
- Welcome | SWOG
SWOG is a worldwide network of researchers that design and conduct cancer clinical trials The group's goal is to change medical practice so it improves the lives of people with cancer
- SWOG Cancer Research Network Meetings
Since 1978, SWOG Cancer Research Network hosts meetings twice yearly in order for members to share ideas, work on trial concepts or ongoing studies, hear about the latest tools and approaches in cancer clinical research, and determine future research directions for the group
- Clinical Trials - SWOG
Along with being publicly funded, SWOG trials seek to improve medical care across the cancer continuum - prevention, treatment, care delivery, symptom control and quality of life, survivorship, and palliative and end-of-life care
- History Impact - SWOG
SWOG is a part of the nation's oldest and largest publicly funded cancer research network Texas pediatrician Grant Taylor, MD, founded the group in Houston in 1956 under a new National Cancer Institute (NCI) program
- Join SWOG Cancer Research Network
Hospitals, clinics, cancer centers, and other institutions that join SWOG help their clinical research staff work better, faster, and smarter SWOG member benefits include: A professional network of more than 20,000 cancer research professionals worldwide, including leading experts in precision medicine, immunotherapy, prevention and
- S2408 | SWOG
SWOG Clinical Trial Number S2107 Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and or Unresectable Colorectal Cancer
- myeloMATCH Overview - SWOG
MyeloMATCH includes treatment trials developed and conducted by Alliance for Clinical Trials in Oncology, Canadian Cancer Trials Group, ECOG-ACRIN Cancer Research Group, and SWOG Cancer Research Network
|
|
|